[2] [2] Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791.

[4] [4] McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions[J]. Semin Cancer Biol, 2021, 75: 38-48.

[7] [7] Wang Q, Liu S. E74-like factor 4 promotes the proliferation, invasion, and migration of colorectal cancer cells via long non-coding RNA integrin subunit beta 8 antisense RNA 1-mediated histone H3 lysine 27 trimethylation modification[J]. Asia Pac J Clin Oncol, 2024, 20(6): 761-770.

[10] [10] Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.

[11] [11] Li H, Yao Q, Li C, et al. Lactoferrin inhibits the development of T2D-induced colon tumors by regulating the NT5DC3/PI3K/AKT/mTOR signaling pathway[J]. Foods, 2022, 11(24): 3956.

[13] [13] Jung G, Hernndez-Illn E, Moreira L, et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(2): 111-130.

[14] [14] Fang D, Ou X, Sun K, et al. m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability[J]. Cancer Sci, 2022, 113(12): 4135-4150.

[16] [16] Cai Y, Li Y, Shi C, et al. LncRNA OTUD6B-AS1 inhibits many cellular processes in colorectal cancer by sponging miR-21-5p and regulating PNRC2[J]. Hum Exp Toxicol, 2021, 40(9): 1463-1473.

[18] [18] Lin X, Zhuang S, Chen X, et al. lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling[J]. Mol Ther, 2022, 30(2): 688-702.